Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

124.26 +2.43 (+1.99%)

Streaming Delayed Price Updated: 10:59 AM EDT, Mar 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Can Healthcare Stocks Continue To Outperform? ↗

September 26, 2022

Large-cap healthcare and biotech stocks have been resilient amidst the market turmoil caused by rising rates and the global geopolitical crisis.

Via Talk Markets

Rare Economic/Technical Signal Has Only Flashed 9 Times In Last 54 Years ↗

September 24, 2022

A rare stock market signal combining technical and economic data was recently flashed. What can we learn from history regarding stock market/recession probabilities?

Via Talk Markets

3 Biotech Stocks to Buy Now for Extraordinary Gains ↗

September 20, 2022

These biotech stocks should deliver big gains to long-term investors who purchase shares at a discount during the bear market.

Via InvestorPlace

Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year ↗

September 19, 2022

The biotech run off a June bottom is great — until you realize you could've netted more.

Via Investor's Business Daily

AskSlim Market Week - Friday, July 22 ↗

July 22, 2022

Technical and cycle analysis, and market commentary.

Via Talk Markets

UUP ETF – Trade Setup Of The Week ↗

July 19, 2022

UUP has been trending higher while the rest of the stock and bond market has been falling.

Via Talk Markets

The Three Best Anti-Aging Stocks to Buy in September ↗

September 19, 2022

These three anti-aging stocks could see recovery ahead. ATHX, LCTX, and UBX can make great long-term investments

Via InvestorPlace

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry ↗

September 12, 2022

President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.

Via InvestorPlace

5 Monster Stock Market Predictions For The Week Of Sept. 12 ↗

September 11, 2022

This week will be interesting, with inflation data Tuesday and Wednesday. There will be a lot of Treasury auctions this week, which will move yields and stocks. The one wrinkle is that the VIX options...

Via Talk Markets

Stocks Drop On August 6 As Financial Conditions Tightening More ↗

September 06, 2022

Today’s battle for the S&P 500 was between 3,900 and 3,920. Right now, the index is just consolidating and is likely to drop to around 3,820 over the near term to fill the gap at that level.

Via Talk Markets

REITs And Utilities Show Glimmer As The S&P Wilts ↗

September 06, 2022

The S&P 500 failed to close below last Thursday's low as Utilities and REITs were bid.

Via Talk Markets

Healthcare Sector Still Looks Good But Lacks Momentum ↗

September 06, 2022

The summer rally is over it’s a holiday weekend with low trading volume and bad news is pervasive. A decent jobs report on Friday brought in buyers in early hours until Russia intervened with a Nord...

Via Talk Markets

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know ↗

August 31, 2022

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

Via Benzinga

Whither Small Caps After Fed’s Tough Talk? ↗

August 29, 2022

For now its better not to “Fight the Fed” because they are fighting the with the market. Now that everyone is scared of the Fed's rhetoric it would be better to wait a week or so as more data and...

Via Talk Markets

3 Investing Themes For The Next 3 Years ↗

August 25, 2022

With all of the noise about Jackson Hole tomorrow and whether they will be hawkish, dovish, pivot or not, we wanted to take a step back and think about broad themes we are/will be pursuing over the...

Via Talk Markets

“Wrong Side Of The Wave” Stock Market (And Sentiment Results) ↗

August 17, 2022

Spreads peaked at 6% in early July and have now rolled over to 4.24% (176 bps) in the past 5 weeks alone. This looks more like a small “aftershock” than a new earthquake.

Via Talk Markets

Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation? ↗

August 15, 2022

The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring...

Via Talk Markets

Exploding Interest Rates May Finally Suck Stocks Lower ↗

August 11, 2022

Stocks moved lower today, despite moving sharply higher to start.

Via Talk Markets

Small Cap Biotechs Perk Up On Dealmaking ↗

August 06, 2022

With M&A picking up we would think smaller deals make sense for large cap biopharma to expand pipelines and complement technology.

Via Talk Markets

Stocks Stall On August 1, As Stagflation Appears To Have Finally Arrived ↗

August 01, 2022

Today financial conditions tightened some, with the IEF/LQD ratio moving up by 45 bps.

Via Talk Markets

Bullish Expanding Falling Wedge ↗

August 01, 2022

I’ve been mentioning lately that I thought that many areas in the PM complex could be building out a potential bullish expanding falling wedge. This is a bullish pattern that few if any chartists...

Via Talk Markets

The 3 Best Market Sectors for the Second Half of 2022 ↗

July 27, 2022

Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into.

Via InvestorPlace

Chris Stapleton “Starting Over” Stock Market (And Sentiment Results) ↗

July 21, 2022

The “hard roads” are stepping in at times like these when others are selling in the hole. We saw it with China stocks bottoming in March. We saw it with Biotech bottoming in May. We may now be seeing...

Via Talk Markets

Broad Market Rallies Despite Currency Headwinds ↗

July 20, 2022

HealthCare and Biotech shares have been strong over the past 30 days as investors have sought trades away from macro and earnings concerns. In times of volatility portfolio strategists may re-balance...

Via Talk Markets

Stocks Dump Hard After Morning Rally Attempt Fails On July 18 ↗

July 18, 2022

Stocks had an exciting day, starting higher and finishing lower. The S&P 500 was up around 1% to start the day and finished the day lower by 85 bps.

Via Talk Markets

Nasdaq Flashes A Stealth Buy Signal: What’s Next? ↗

July 18, 2022

The Nasdaq is now trading above its 20-day exponential moving average.

Via Talk Markets

7 Biotech Stocks to Buy for Q3 ↗

July 18, 2022

These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.

Via InvestorPlace

Small Cap Biotech Stocks Are Trending Well ↗

July 18, 2022

Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx.

Via Talk Markets

CNBC's Final Trades: Biotech, CVS Health, Walt Disney And This Stock That Could Benefit From Taiwan Semiconductor's Earnings Release ↗

July 14, 2022

On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management chose SPDR S&P Biotech ETF (NYSE: XBI).

Via Benzinga

CNBC Fast Money Favorites: AMD, CVS, And One Of The Worst Performers In The S&P 500 Today ↗

July 13, 2022

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The...

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.